Breakwater Capital Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $819K | Buy |
1,839
+53
| +3% | +$23.6K | 0.13% | 165 |
|
|
2025
Q1 | $866K | Buy |
1,786
+27
| +2% | +$13.1K | 0.15% | 133 |
|
|
2024
Q4 | $708K | Buy |
1,759
+14
| +0.8% | +$5.64K | 0.14% | 145 |
|
|
2024
Q3 | $812K | Buy |
1,745
+21
| +1% | +$9.77K | 0.16% | 128 |
|
|
2024
Q2 | $808K | Buy |
1,724
+130
| +8% | +$60.9K | 0.18% | 121 |
|
|
2024
Q1 | $666K | Buy |
1,594
+308
| +24% | +$129K | 0.17% | 124 |
|
|
2023
Q4 | $566K | Buy |
1,286
+314
| +32% | +$138K | 0.16% | 122 |
|
|
2023
Q3 | $359K | Buy |
972
+35
| +4% | +$12.9K | 0.12% | 157 |
|
|
2023
Q2 | $330K | Buy |
+937
| New | +$330K | 0.12% | 158 |
|